The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


Zerofen 10% Oral Suspension

10 percent weight/volume Oral suspension

Chanelle Pharmaceuticals Manufacturing LimitedVPA10987/017/001

Main Information

Trade NameZerofen 10% Oral Suspension
Active SubstancesFenbendazole
Strength10 percent weight/volume
Dosage FormOral suspension
Licence HolderChanelle Pharmaceuticals Manufacturing Limited
Licence NumberVPA10987/017/001

Group Information

ATC CodeQP52AC13 fenbendazole
Therapeutic ClassEndoparasiticide
SpeciesCattle

Status

Authorised/WithdrawnAuthorised
Licence Issued04/01/1991
Legal StatusLM: Licensed Merchant as defined in relevant national legislation

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back